Abstract

This chapter contains sections titled: The Concept of Rational Drug Design 3D Structure-Based Drug Design Ligand-Based Drug Design Target Selection and Validation Personalized Therapy with Kinase Inhibitors The NCL™ Technology and Extended Pharmacophore Modeling (Prediction-Oriented QSAR) Non-ATP Binding Site-Directed or Allosteric Kinase Inhibitors The Master Keys for Multiple Target Kinase Inhibitors Conclusions References

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.